Predictive Oncology Inc. (NASDAQ: POAI)
is a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.
We dedicate our mission to the millions of healthcare professionals and scientists who take the fight to cancer with every shift. Without their dedication, advancements and cures would be impossible. Likewise, we keep cancer patients and their families in our hearts as we work to eliminate cancer from our lives.
Let us tell you about Predictive Oncology.
Using artificial intelligence, we utilize our collection or 150K+ cancer tumors, categorized by patient type, against drug compounds to determine optimal therapies to be used to eliminate cancer.
Further, the drug discovery community realizes that a genomics-based approach is alone insufficient to achieve the promise of personalized therapeutics. Our multiomic approach stands a much greater chance of success.